Cough — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for cough. 17 active patents protecting 2 drugs from 2+ originators. First major cliff: 2032. Daily refresh.

2
Approved drugs
17
Active US patents
54/100
Avg vulnerability
—
Annual revenue covered

Originators in Cough

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Fresenius Kabi 14 patents Generic (multiple manufacturers) 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating cough. Each bar = one year. Y-axis scaled to peak year (7 patents).

7
32
7
34
3
35

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Dilaudid-Hp
Hydromorphone Hydrochloride
 Fresenius Kabi 14 46 — 2032-04-23
Mucinex
guaifenesin
 Generic (multiple manufacturers) 3 62 — 2035-11-13

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
10105324 Mucinex method of use 62 2035-11-13
9549907 Mucinex method of use 62 2035-11-13
9808431 Mucinex method of use 62 2035-11-13
9731082 Dilaudid-Hp formulation 56 2032-04-23
9248229 Dilaudid-Hp formulation 50 2034-03-12
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9248229 Dilaudid-Hp formulation 42 2034-03-12
9248229 Dilaudid-Hp formulation 42 2034-03-12
9248229 Dilaudid-Hp formulation 42 2034-03-12
9248229 Dilaudid-Hp formulation 42 2034-03-12
9248229 Dilaudid-Hp formulation 42 2034-03-12
9248229 Dilaudid-Hp formulation 42 2034-03-12
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23
9731082 Dilaudid-Hp formulation 48 2032-04-23

Related